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Abstract
Introduction: Symmetrical peripheral gangrene is an uncommon but devastating complication in critically ill
patients, and it has a high mortality. It is seen in a wide variety of medical conditions, presenting as symmetrical
gangrene of two or more extremities without large blood vessel obstruction.
Case presentation: We report a case of a 44-year-old Chinese man who was diagnosed with alcohol-related
severe acute pancreatitis and presented with systemic inflammatory response syndrome and intractable vomiting.
On the fourth day of admission, the patient developed cyanosis and gangrene of the fingers bilaterally. His cyanosis
and gangrene did not resolve despite tapering of the vasopressor treatment. Gradually, his digital gangrene
improved after administration of anti-platelet medication and pentoxifylline.
Conclusions: To the best of our knowledge, this is the first case report of symmetrical peripheral gangrene
occurring after acute pancreatitis with successful resolution. We highlight the importance of prompt and
aggressive fluid resuscitation and consideration of multiple treatment options to prevent a hypovolemic state
caused by acute pancreatitis.
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Introduction
Severe acute pancreatitis is a serious condition that can
result in both local and systemic complications. Systemic
complications can involve the gastrointestinal (GI), car-
diovascular, renal, hepatic, and neurological systems, as
well as the vascular system. Such complications add to
morbidity and mortality, but they have rarely been char-
acterized in symmetrical peripheral gangrene (SPG).
SPG, sometimes termed purpura fulminans, is uncom-
mon but not rare in critically ill patients. It is characterized
by a distal ischemic change of two or more extremities
without large blood vessel occlusion or vasculitis. The
latter complication is usually observed in the setting of
disseminated intravascular coagulation (DIC), sepsis,
low cardiac output state, collagen vascular disease, anti-
phospholipid syndrome, and drugs such as ergot,
vasopressin, and noradrenaline [1–3]. It is rarely associ-
ated with acute pancreatitis. In this report, we describe
a case of a man who developed SPG as a complication
of severe acute pancreatitis.
Case presentation
A 44-year-old Chinese man, who was an occasional
smoker and social drinker, presented with complaints of
acute pain in his upper abdomen and vomiting of par-
ticulate material resembling coffee grounds during the
24h before admission. His pain had developed 8–10h
after consumption of Kaoliang liquor (3000ml of home-
made liquor consisting of approximately 58% alcohol)
over a period of 3 days while at home. Initially, he pre-
sented with epigastric pain, nausea, vomiting, and watery
diarrhea. Because of aggravation of epigastric pain with
subsequent vomiting of coffee ground–like material and
passage of tarry stools, he was admitted to the emer-
gency room by ambulance. His pain was dull, aching,
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and became aggravated upon eating. He had intractable
vomiting approximately 30 times and subsequently vom-
ited coffee ground–like material on the day of admission.
His past medical history included two episodes of alcohol-
related acute pancreatitis without mention of diabetes mel-
litus, claudication, cardiovascular disease, or illicit drug
abuse. The patient denied steatorrhea, maldigestion, or
recent body weight loss, which excluded possible chronic
pancreatitis.
His initial vital signs revealed blood pressure of 74/
27mmHg, heart rate of 152 beats/min, and body
temperature of 38.7 °C. His clinical picture was compatible
with systemic inflammatory response syndrome (SIRS)
with shock status. His physical examination revealed that
his abdomen was mildly distended with tenderness over
the epigastric area. Chest, extremity, and other systemic
examinations were unremarkable. Routine laboratory in-
vestigations revealed a hemoglobin level of 11.6g/dl, white
blood cell count of 14,000/μl, amylase of 680U/L, lipase of
1125U/L, albumin of 2.0g/dl, total bilirubin of 0.61mg/dl,
alkaline phosphatase of 110U/L, γ-glutamyl transferase of
70U/L, C-reactive protein of 24.49mg/dl, lactate dehydro-
genase of 362U/L, and creatine phosphokinase of 489U/L.
He had impaired renal function with blood urea nitrogen
of 28mg/dl and creatinine of 2.3mg/dl. Impaired liver func-
tion with aspartate transaminase of 250U/L and alanine
transaminase of 47U/L were also noted. He had high anion
gap metabolic acidosis characterized by a lactic acid level
of 5.75mmol/L, arterial blood pH of 7.058, bicarbonate
level of 5.1mmol/L, anion gap of 32.1, and ethanol of
116mg/dl. His laboratory test result for serum ketone bod-
ies was negative. His coagulation profile was consistent
with SIRS with shock status and elevated D-dimer levels.
His initial central venous pressure was recorded as
4mmHg. A diagnostic screen for sepsis showed unre-
markable blood culture results (Table 1). His Ranson’s
criteria scores were 3 on admission and 2 after 48h.
Ultrasonography and computed tomography (CT) of
the abdomen and abdomen revealed a picture compat-
ible with acute pancreatitis, CT severity index grade E.
According to the revised Atlanta classification of pan-
creatitis, the patient was diagnosed with severe acute
pancreatitis due to persistent organ failure (profound shock
lasting for more than 48h and acute kidney injury with
oliguria status after emergent hemodialysis).
He was treated promptly and aggressively with intra-
venous fluids with normal saline. His intravenous fluids
were given as a 20ml/kg bolus, followed by a mainten-
ance dose of 3ml/kg/h. He was also prescribed analgesic
for pain relief. Because the patient had profound shock and
a poor response to fluid resuscitation, a vasopressor was
administered with intravenous norepinephrine at an infu-
sion rate of 4μg/min for 2 days through the central venous
line. This was discontinued after his blood pressure was
restored. Upper GI panendoscopy was conducted because
of vomitus of coffee ground material, which revealed a
Mallory-Weiss tear and acute gastric ulcer with a history
of recent hemorrhage. An antibiotic (ceftriaxone) and a
proton pump inhibitor (omeprazole) were administered.
Continuous renal replacement therapy was initiated for re-
fractory acidosis and contrast media removal. The patient
responded well to aggressive, conservative management.
On the fourth day after hospitalization, a bilateral bluish
discoloration of the fingers was noted. A gradual painful
sensation developed 5 days after an acrocyanotic lesion
was found (Fig. 1).
Dry gangrene and a limited range of motion of the fingers
developed 9 days after the lesion was noted. Peripheral
Table 1 Survey for symmetrical peripheral gangrene




ESR, mm/h (0–15) 69mm/h
RPR/VDRL test Negative
Cold agglutinin antibodies (<1:16×(−); 1:16X(+)) <1:16
C3, mg/dl (86–160) 143
C4, mg/dl (17–45) 30
Protein C, % (70–140%) 78.7
Anti-thrombin III, % (75–125%) 73.4
c-ANCA, IU/ml (<2) 0.1
ANA (<1:20) <1:20
Anti-DNA, <Day 12 after admission10(−); 10–15(+/−); >15(+) 0.1(−)
Anti-cardiolipin IgM, MPL U/ml (<10) 0.1
Anti-cardiolipin IgG, IU/ml (<10) 0.2
DIC profile
Platelets (150,000–400,000/μl) 170,000/μl
PT, s (8.0–12.0) 12.5
INR 1.27
aPTT, s (24.3–32.7) 33.1
D-dimer, ng/ml (<500) 4441.30
Fibrinogen, mg/dl (150–350) 559.5
CEA, ng/ml (0–5) 3.77
AFP, ng/ml (1.09–8.04) 3.20
CA 19-9, U/ml (0–37) 6.52
PSA, ng/ml (0–4) 0.622
AFP, α-fetoprotein; ANA, anti-nuclear antibodies; c-ANCA, cytoplasmic anti-
neutrophil cytoplasmic antibodies; aPTT, activated partial thromboplastin
time; C3, complement component 3; C4, complement component 4; CA 19-9,
carbohydrate antigen 19-9; c-ANCA, cytoplasmic anti-neutrophil cytoplasmic
antibodies; CEA, carcinoembryonic antigen; DIC, Disseminated intravascular
coagulation; ESR, erythrocyte sedimentation rate; HBsAg, hepatitis B surface
antigen; HCV, hepatitis C virus; Ig, immunoglobulin; INR, international normalized
ratio; PSA, prostate-specific antigen; PT, prothrombin time; RPR/VDRL, rapid
plasma regain/venereal disease research laboratory
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pulses were palpable in both the upper and lower extrem-
ities. The results of laboratory tests for SPG, compris-
ing infection, malignancy, and the autoimmune system,
were unremarkable (Table 1). Transesophageal echocar-
diography, carotid Doppler ultrasound, and sonography
of the upper extremity vessels also were unremarkable.
The patient was administered two doses of oral aspirin
75mg/day and two doses of oral pentoxifylline 400mg/day
for 20 days. Because of upper GI tract bleeding noted on
admission, heparin was not considered. The gangrenous
lesion was kept warm and was not touched, as much as
possible. The patient’s condition improved steadily over
the next 7 days. His pain decreased, and his range of mo-
tion improved. Gradual desquamation of his finger skin
occurred, with shedding of gangrenous scabs from the tips
of his fingers and complete resolution (Fig. 2a, b). The pa-
tient was discharged from the hospital stay 26 days later.
The patient responded well to the treatment and returned
to his normal daily activities during outpatient follow-up.
Discussion
SPG is a relatively rare phenomenon characterized by
symmetrical distal ischemic damage that leads to gan-
grene of two or more sites in the absence of large blood
vessel obstruction, where vasoconstriction rather than
thrombosis is implicated as the underlying pathophysi-
ology [1, 4]. The gangrenous lesions initially appear in
the form of acrocyanotic and dusky discolorations of the
skin starting from the distal extremity within 24–48h
and resemble lesions associated with erythematous cold
extremity exposure. Gangrene most commonly occurs in
the distal extremities, such as the fingers, toes, tips of
the nose, and ear lobules, whereas the lips or genitalia
may be affected in severe cases [5]. Peripheral pulses are
usually palpable as a result of sparing of the large ves-
sels. Up to 85% of patients with SPG attributed to DIC
and other proposed mechanisms, such as the Shwartzman
reaction, bacterial endotoxin release, low flow states, and
spastic process of vessels [2, 6–8]. The mortality rate
ranges from 30% to 50% of surviving patients, in whom it
is common for at least one limb to be amputated [2, 4, 9].
A wide array of infective and non-infective etiological
factors have been linked with the development of SPG,
such as bacterial and viral infections (e.g., Clostridium
perfringens and Neisseria meningitides), sepsis, shock
status, cardiovascular problems, and treatment with
vasoactive agents, such as vasopressin, dopamine, and
noradrenaline [3].
We conducted a review of the English-language med-
ical literature, which revealed rare occasions of patients
experiencing SPG with presentation in only the upper
limb precipitated by acute pancreatitis [10, 11]. Blue toe
syndrome complicated by acute pancreatitis or arteriopan-
creatic syndrome may be identical to SPG at different
stages of the clinical course.
Acute pancreatitis usually presents with low volemic
state, hypercoagulation, and hemoconcentration, which
can contribute to low flow and vascular disturbance. This not
only leads to local pancreatic microcirculatory impairment
but also involves distantmicrovascular andmacrovascular cir-
culation. It has varied presentations, ranging from isolated
intravascular thrombosis due to DIC, whichmay result in vas-
cular occlusion and further progression to SPG.
Fig. 1 Acrocyanosis on day 9 after admission
Fig. 2 a Day 12 after admission: gangrenous change over the fingers on
day 9 after acrocynosis noted. b Day 26 after admission: resolution of
symmetrical peripheral gangrene on day 22 after acrocyanosis noted.
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In our patient, we collected laboratory data that did
not resemble DIC. Though high-dose vasopressor treat-
ment related to SPG is well described in the literature
[3], we administered norepinephrine to our patient at a
suboptimal dose and only for a brief period (2 days) that
did no correlate with the timeline of SPG, which devel-
oped 2 days after discontinuation of the vasopressor.
Thus, we believe that acute pancreatitis in our patient
was highly associated with the occurrence of SPG. In pa-
tients with acute pancreatitis complicated by SPG, fluid
resuscitation should be administered first, instead of vaso-
pressor treatment, except for cases where there is re-
fractory shock status. Prompt fluid resuscitation, empirical
antibiotics, and anti-coagulant therapy may improve the
flow state and control the underlying infection, which will
further alleviate the DIC episode.
Conclusions
We report this case to highlight the importance of early
identification and treatment of pre-gangrenous changes
in limbs to avoid amputation. This is the first time, to
the best of our knowledge, that imaging has captured
the clinical sequence of events from onset of gangrene
to localization of a typically disseminating phenomenon.
During the regenerative process, meticulous care of the
affected areas is required to prevent infections and ensure
a favorable outcome.
To the best of our knowledge, this is the first case report
of SPG after acute pancreatitis with successful resolution.
We highlight the importance of early, aggressive fluid re-
suscitation and multiple treatment options to prevent a
hypovolemic state caused by acute pancreatitis.
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